/
OSUR
$4.50+$0.04 (+0.90%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$307.1M
69M shares
52-week range
$2.08 – $4.58
97% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.35%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-5.87
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $181.7M | $154.6M | $171.7M | $233.7M | $387.5M | $405.5M | $185.8M | $115.0M |
| Cost of revenue | $68.1M | $60.0M | $69.9M | $116.1M | $239.0M | $226.1M | $109.6M | $66.8M |
| Gross profit | $113.6M | $94.6M | $101.9M | $117.6M | $148.4M | $179.4M | $76.2M | $48.2M |
| Gross margin | 62.5% | 61.2% | 59.3% | 50.3% | 38.3% | 44.2% | 41.0% | 41.9% |
| R&D | $16.3M | $19.6M | $31.0M | $34.2M | $36.2M | $33.2M | $24.4M | $42.5M |
| Operating income | $39.3M | $9.0M | −$5.9M | −$11.6M | −$5.2M | $54.1M | −$20.6M | −$68.1M |
| EBITDA | $45.7M | $16.3M | $3.5M | $2.4M | −$1.7M | $76.2M | −$6.8M | −$57.0M |
| Net income | $20.4M | $16.7M | −$14.9M | −$23.0M | −$17.1M | $53.7M | −$19.5M | −$68.7M |
| Net margin | 11.2% | 10.8% | -8.7% | -9.8% | -4.4% | 13.2% | -10.5% | -59.8% |
| EPS (diluted) | 0.33 | 0.27 | -0.22 | -0.32 | -0.25 | 0.72 | -0.26 | -0.94 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $120M | $-1.05 | $-1.06–$-1.04 | 1 |
| 2027 | $128M | $-0.82 | $-0.83–$-0.81 | 1 |
| 2028 | $130M | $-0.10 | $-0.10–$-0.10 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.13
Price
$4.50
Implied downside
-97%
Peer comparison
OraSure Technologies Inc
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
www.orasure.com- Employees
- 500
- IPO / List date
- Nov 17, 1986
- HQ
- BETHLEHEM, PA
Held by traders on TradeandTell
No one on the platform currently holds OSUR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 2,083,303 | $6.2M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded OSUR yet.
